Melton B Affrime

Title: Melton B Affrime: Innovator in Allergy Treatment

Introduction

Melton B Affrime is a notable inventor based in Warren, NJ (US). He has made significant contributions to the field of medicine, particularly in the treatment of allergic and inflammatory conditions. With a total of 6 patents to his name, Affrime's work has had a meaningful impact on healthcare.

Latest Patents

Affrime's latest patents focus on methods for treating allergic and inflammatory conditions. One of his notable inventions involves a method of treating and/or preventing allergic and inflammatory conditions of the skin or upper and lower airway passages. This includes conditions such as seasonal allergic rhinitis, perennial allergic rhinitis, and chronic idiopathic urticaria in individuals over 12 years old. The method involves administering an amount of desloratadine, specifically 2×2.5 mg or 5 mg per day, for a duration sufficient to achieve a geometric mean steady state maximum plasma concentration of desloratadine in the range of about 2.90 ng/mL to about 4.54 ng/mL, or an arithmetic mean steady state maximum plasma concentration in the range of about 3.2 ng/mL to about 5.0 ng/mL.

Career Highlights

Affrime is associated with Schering Corporation, where he has been able to apply his innovative ideas in a professional setting. His work has contributed to advancements in allergy treatment, showcasing his dedication to improving patient care.

Collaborations

Throughout his career, Affrime has collaborated with notable colleagues, including David L Cutler and Paul William Glue. These partnerships have likely enhanced the development and implementation of his innovative treatments.

Conclusion

Melton B Affrime stands out as a significant figure in the field of allergy treatment, with a focus on innovative methods that improve the quality of life for individuals suffering from allergic conditions. His contributions continue to influence the medical community positively.